| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | 0 |
Sells | $4,715,330 | 10 | 100 |
| Naylor Stuart | CHIEF DEV. OFFICER | 0 | $0 | 4 | $997,970 | $-997,970 |
| Giroux Richard | CFO & COO | 0 | $0 | 3 | $1.83M | $-1.83M |
| Forbes Alexandria | PRESIDENT & CEO | 0 | $0 | 3 | $1.89M | $-1.89M |
MeiraGTx Holdings plc operates as a clinical-stage gene therapy company, dedicated to pioneering therapeutic solutions for individuals afflicted by serious illnesses. Its development efforts span a broad spectrum of conditions, encompassing ocular diseases like inherited forms of blindness, as well as xerostomia (dry mouth) that often follows radiation treatment for head and neck cancers. The company also targets various degenerative and neurodegenerative disorders, notably amyotrophic lateral sclerosis (ALS) and Parkinson's disease. Currently, …
Over the last 12 months, insiders at MeiraGTx Holdings plc have bought $0 and sold $4.72M worth of MeiraGTx Holdings plc stock.
On average, over the past 5 years, insiders at MeiraGTx Holdings plc have bought $10M and sold $2.65M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 1,250,000 shares for transaction amount of $5M was made by PERCEPTIVE ADVISORS LLC () on 2024‑08‑12.
| 2026-10-20 | Sale | Giroux Richard | CFO & COO | 56,000 0.0582% | $9.95 | $557,200 | -4.66% | |
| 2026-10-06 | Sale | Naylor Stuart | CHIEF SCI OFCR, OPHTHALMOLOGY | 27,659 0.03% | $10.64 | $294,292 | -8.23% | |
| 2026-08-18 | Sale | Forbes Alexandria | PRESIDENT & CEO | 62,000 0.0668% | $13.86 | $859,320 | -20.23% | |
| 2026-07-21 | Sale | Giroux Richard | CFO & COO | 56,000 0.062% | $12.51 | $700,560 | -3.12% | |
| 2026-07-07 | Sale | Naylor Stuart | CHIEF SCI OFCR, OPHTHALMOLOGY | 2,547 0.0026% | $13.86 | $35,301 | -15.86% | |
| 2026-07-07 | Sale | Naylor Stuart | CHIEF SCI OFCR, OPHTHALMOLOGY | 27,659 0.0318% | $14.80 | $409,470 | -15.86% | |
| 2026-05-19 | Sale | Forbes Alexandria | PRESIDENT & CEO | 62,000 0.0653% | $9.17 | $568,540 | +29.41% | |
| 2026-04-21 | Sale | Giroux Richard | CFO & COO | 56,000 0.0667% | $10.22 | $572,320 | +9.34% | |
| 2026-04-07 | Sale | Naylor Stuart | CHIEF DEV. OFFICER | 27,661 0.0334% | $9.36 | $258,907 | +15.25% | |
| 2026-03-24 | Sale | Forbes Alexandria | PRESIDENT & CEO | 62,000 0.077% | $7.41 | $459,420 | +44.26% | |
| 2025-10-21 | Sale | Giroux Richard | CFO & COO | 24,000 0.0286% | $8.87 | $212,880 | +0.22% | |
| 2025-10-07 | Sale | Forbes Alexandria | PRESIDENT & CEO | 47,500 0.0584% | $8.39 | $398,525 | +7.54% | |
| 2025-07-22 | Sale | Giroux Richard | CFO & COO | 24,000 0.0296% | $8.52 | $204,480 | -4.19% | |
| 2025-07-08 | Sale | Forbes Alexandria | PRESIDENT & CEO | 47,500 0.0584% | $7.97 | $378,575 | +1.98% | |
| 2025-04-22 | Sale | Giroux Richard | CFO & COO | 24,000 0.0318% | $6.00 | $144,000 | +23.45% | |
| 2025-04-08 | Sale | Forbes Alexandria | PRESIDENT & CEO | 47,500 0.0559% | $5.34 | $253,650 | +46.09% | |
| 2025-01-21 | Sale | Giroux Richard | CFO & COO | 24,000 0.0304% | $6.29 | $150,960 | +17.16% | |
| 2025-01-08 | Sale | Forbes Alexandria | PRESIDENT & CEO | 11,661 0.0148% | $6.30 | $73,464 | +18.19% | |
| 2025-01-07 | Sale | Forbes Alexandria | PRESIDENT & CEO | 35,839 0.0469% | $6.47 | $231,878 | +18.38% | |
| 2024-08-12 | PERCEPTIVE ADVISORS LLC | 1.25M 1.9341% | $4.00 | $5M | +55.25% |
| PERCEPTIVE ADVISORS LLC | 12531103 13.0474% | $119.3M | 6 | 0 | +2.25% | |
| PERCEPTIVE LIFE SCIENCES MASTER FUND LTD | 10 percent owner | 6007746 6.2553% | $57.19M | 1 | 0 | +18.44% |
| Seligman Nicole | director | 5000 0.0052% | $47,600.00 | 1 | 0 | <0.0001% |
| Zeldin Robert K | CHIEF MEDICAL OFFICER | 5000 0.0052% | $47,600.00 | 1 | 0 | <0.0001% |
| Wollin Robert J | GENERAL COUNSEL AND SECRETARY | 1000 0.001% | $9,520.00 | 1 | 0 | <0.0001% |
$100,473,344 | 83 | 9.53% | $826.91M | |
$15,410,062 | 81 | 39.69% | $975.93M | |
$5,911,307 | 70 | -1.38% | $884.8M | |
$1,108,102,085 | 66 | 36.91% | $755.04M | |
$11,663,618 | 57 | 32.20% | $934.29M |
| Increased Positions | 65 | +52.85% | 7M | +10.86% |
| Decreased Positions | 46 | -37.4% | 6M | -8.94% |
| New Positions | 21 | New | 1M | New |
| Sold Out Positions | 12 | Sold Out | 273,304 | Sold Out |
| Total Postitions | 142 | +15.45% | 65M | +1.92% |
| Perceptive Advisors Llc | $98,610.00 | 15.78% | 12.63M | 0 | 0% | 2025-09-30 |
| Sanofi | $95,264.00 | 15.25% | 12.2M | 0 | 0% | 2025-09-30 |
| Johnson & Johnson | $51,867.00 | 8.3% | 6.64M | 0 | 0% | 2025-09-30 |
| Adage Capital Partners Gp, L.L.C. | $32,682.00 | 5.23% | 4.18M | -2M | -30.66% | 2025-09-30 |
| Prosight Management, Lp | $31,939.00 | 5.11% | 4.09M | -497,914 | -10.85% | 2025-09-30 |
| Rubric Capital Management Lp | $29,104.00 | 4.66% | 3.73M | 0 | 0% | 2025-09-30 |
| Blackrock, Inc. | $21,667.00 | 3.47% | 2.77M | -88,136 | -3.08% | 2025-09-30 |
| 683 Capital Management, Llc | $20,501.00 | 3.28% | 2.63M | -65,000 | -2.42% | 2025-09-30 |
| Millennium Management Llc | $20,001.00 | 3.2% | 2.56M | +2M | +226.16% | 2025-09-30 |
| J. Goldman & Co Lp | $14,065.00 | 2.25% | 1.8M | -243,643 | -11.92% | 2025-09-30 |